Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why GenMark Diagnostics Shares Jumped

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of GenMark Diagnostics (NASDAQ: GNMK  ) were returning positive results today, jumping as much as 13% after a strong earnings report.

So what: The development-stage molecular diagnostics company beat estimates on top and bottom lines with a revenue of $9.4 million, a 364% increase from the year before, and an EPS loss of $0.15 was better than the $0.21 loss analysts expected. CEO Hany Massarany noted that a strong flu season and the continued expansion of the company's installed base contributed to the better-than-expected quarter. Gross margin also dramatically improved to 50% from 20% in the same quarter a year ago.

Now what: Guidance for 2013 also beat estimates, as GenMark expects revenue to grow 70% to $35 million in the year. Analysts had expected just $30.6 million. The company also predicts its installed base of analyzers to grow by about 50%, or an additional 150 machines. Still, GenMark seems at least a few years from profitability, and it's hard to justify its current $400 million market cap. Shares have more than tripled in the past year, and it seems like it could be time to cool off.

Even if GenMark is popping today, macro trends will continue to affect the overall stock market. Warren Buffett referred to one trend as "the tapeworm that's eating at American competitiveness." Find out what it is in our free report: "What's Really Eating At America's Competitiveness." You'll also discover an idea to profit as companies work to eradicate this efficiency-sucking tapeworm. Just click here for free, immediate access.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2310743, ~/Articles/ArticleHandler.aspx, 9/26/2016 10:34:15 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,146.88 -114.57 -0.63%
S&P 500 2,153.90 -10.79 -0.50%
NASD 5,277.34 -28.41 -0.54%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/26/2016 10:17 AM
GNMK $11.61 Down -0.09 -0.77%
GenMark Diagnostic… CAPS Rating: No stars